器官保存市场－全球产业规模、份额、趋势、机会及预测（按解决方案、技术、器官类型、最终用户、地区和竞争格局划分，2021-2031年）

全球器官保存市场预计将从 2025 年的 2.8481 亿美元成长到 2031 年的 3.8716 亿美元，年复合成长率为 5.25%。

该市场涵盖先进的机械灌注系统和专用化学溶液，旨在维持捐赠器官在保存和运输过程中的生理功能和细胞活力。推动这一市场成长的关键因素包括全球慢性疾病（如心血管疾病和糖尿病）发病率的上升，这些疾病显着增加了末期器官衰竭的风险。此外，人口老化加剧，以及使得高风险捐赠者器官移植成为可能的临床突破，都推动了对可靠保存技术的需求，以确保良好的移植后效果。

儘管有这些成长要素，但市场仍面临一个重大障碍：可供移植的捐赠器官供应有限，而移植需求却居高不下，两者之间存在持续缺口。这种短缺限制了手术总数，也限制了器官保存解决方案的潜在市场。根据联合国器官捐赠网络（UNOS）的数据，2024年美国器官移植手术数量达到创纪录的48,149例（比上年增长3.3%），但这一数字仍然不足以满足大量等待救命手术的患者的需求。

市场驱动因素

常温和低温机械灌注技术的突破正在改变整个产业，使器官存活时间远远超出传统静态冷藏的限制。这些先进的机械系统在运输过程中提供持续的代谢支持和监测，减轻缺血性损伤，并使以往无法使用的扩大标准供体器官得以利用。这些动态保存技术的商业性成功体现在主要产业参与者的财务表现上。例如，TransMedics Group, Inc.在2024年10月公布，其第三季收入净额年增64%至1.088亿美元，这主要得益于其专有器官护理系统的日益普及。

同时，政府的各项措施和旨在促进器官捐赠者登记的国家策略，正推动需要器官保存技术的移植手术数量增加。卫生部门正在简化捐赠流程并加强基础设施建设，从而增加器官供应。这带动了对器官运输设备和保存耗材的需求。根据英国国家医疗服务体系（NHS）血液和移植服务中心2024年7月发布的报告，英国2023/24财年的遗体捐赠者人数将达到1510人，增幅达6%。临床活动的增加也推动了市场整合，例如，Getinge AB公司于2024年以约4.77亿美元的价格收购了Paragonix Technologies公司，将其先进的器官保存设备纳入其医疗保健产品组合。

市场挑战

适当的捐赠器官严重短缺仍然是全球器官保存市场扩张的一大障碍。有限的器官供应与巨大的移植需求之间持续存在的不平衡限制了该行业的成长潜力。由于保存技术仅在获取器官进行运输时使用，因此市场成长本质上与捐赠率相关，而非终末期器官衰竭患者总数。因此，这些专用灌注系统和解决方案的市场机会受到实际移植手术数量有限的限制。

这种差距的严重性显而易见：器官捐赠组织协会预测，到2025年，日本等待器官移植的人数将超过10.4万人。这个数字凸显了可用资源与临床需求之间的脱节，等待移植的患者人数远远超过捐赠者人数。这限制了储存设备製造商的收入潜力，也阻碍了市场充分利用全球慢性病流行所带来的需求。

市场趋势

外包模式和器官移植服务的兴起正在重塑市场模式。市场关注点正从购买大型设备转向提供全面的物流支持，移植中心和医院越来越多地采用承包服务网络，负责器官获取、灌注和运输，从而显着减轻手术团队的工作量。这种转变使医疗机构无需在硬体和专业人员方面进行大量前期投资，即可利用先进的灌注技术。例如，《医疗采购商》（Medical Buyer）在2025年10月报道称，TransMedics集团的季度收入增长了32%，达到1.438亿美元。这主要得益于该公司扩大了对国家器官移植服务计划（NOP）物流网络的使用，而不仅仅是主机销售。

同时，自动化和携带式器官运输系统的进步正在彻底改变捐赠器官的运输方式，并改善移植后的预后。与传统的静态冷藏不同，这些先进设备能够在运输过程中主动调节和监测器官的环境，从而提供显着降低长期临床风险的保护。将温度控制和持续监测功能整合到携带式设备中，已在提高器官存活率方面展现出实际的好处。器官捐赠联盟 (ODA) 于 2025 年 6 月发布的 GUARDIAN-Heart 註册数据显示，使用 Paragonix SherpaPak 系统保存的心臟，与使用传统冰块保存的心臟相比，四年死亡率降低了 54%。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球器官保存市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 解决方案提供者（威斯康辛大学解决方案 (UW Solutions)、Custodial HTK、 Perfadex、其他解决方案）
  • 依技术分类（静态冷冻保存、低温机械灌注、常温机械灌注）
  • 依器官类型（肾臟、肝臟、肺臟、心臟、胰臟）
  • 依最终使用者（器官移植中心、医院、专科诊所）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美器官保存市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲器官保存市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区器官保存市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲器官保存市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美器官保存市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球器官保存市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Paragonix Technologies, Inc
• XVIVO Perfusion AB
• Dr. Franz KOhler Chemie GmbH
• OrganOx Limited
• Bridge to Life（Europe）Ltd.
• Waters Medical Systems, LLC
• Preservation Solutions Inc.
• Artivion, Inc
• Vascular Perfusion Solutions, Inc
• Global Transplant Solutions

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Organ Preservation Market is projected to expand from a valuation of USD 284.81 Million in 2025 to USD 387.16 Million by 2031, progressing at a CAGR of 5.25%. This market consists of advanced mechanical perfusion systems and specialized chemical solutions designed to sustain the physiological function and cellular viability of donor organs during storage and transport. Key factors driving this growth include the rising global incidence of chronic conditions, such as cardiovascular disorders and diabetes, which significantly heighten the risk of end-stage organ failure. Additionally, the increasing geriatric population, combined with clinical breakthroughs that allow for the transplantation of higher-risk donor organs, is fueling the demand for reliable preservation technologies to secure positive post-transplant results.

Despite these growth drivers, the market faces a substantial obstacle in the form of a persistent gap between the limited supply of viable donor organs and the high demand for transplants. This shortage restricts the total number of procedures, thereby limiting the addressable market for preservation solutions. Data from the United Network for Organ Sharing indicates that while a record 48,149 organ transplants were conducted in the United States in 2024-a 3.3 percent rise from the prior year-this volume is still inadequate to meet the needs of the extensive waiting list of patients requiring life-saving surgeries.

Market Driver

Technological breakthroughs in normothermic and hypothermic machine perfusion are transforming the industry by extending organ viability far beyond the limits of conventional static cold storage. These advanced mechanical systems provide continuous metabolic support and monitoring during transit, reducing ischemic damage and enabling the use of organs from extended criteria donors that were once considered unusable. The commercial success of these dynamic preservation methods is reflected in the financial performance of key industry players; for example, TransMedics Group, Inc. reported in October 2024 that their third-quarter net revenue surged to USD 108.8 million, a 64 percent increase year-over-year, largely attributed to the increased adoption of their proprietary organ care systems.

Simultaneously, government efforts and national strategies designed to boost donor registration are increasing the number of procedures that require preservation technologies. By streamlining donation processes and enhancing infrastructure, health authorities are effectively increasing organ availability, which in turn drives demand for transport units and preservation consumables. According to a July 2024 report by NHS Blood and Transplant, the United Kingdom saw the number of deceased donors rise to 1,510 in the 2023/24 fiscal year, a 6 percent increase. This rise in clinical activity is also spurring market consolidation, illustrated by Getinge AB's 2024 agreement to acquire Paragonix Technologies for approximately USD 477 million to incorporate advanced preservation devices into its medical portfolio.

Market Challenge

The severe shortage of appropriate donor organs remains a significant barrier to the expansion of the Global Organ Preservation Market. This ongoing imbalance between the finite supply of organs and the high demand for transplantation creates a ceiling on the industry's growth potential. Because preservation technologies are utilized only when an organ is procured for transport, market growth is inherently linked to donation rates rather than the sheer volume of patients suffering from end-stage organ failure. As a result, the market opportunity for these specialized perfusion systems and solutions is constrained by the limited number of transplant procedures actually performed.

The extent of this disparity highlights the severity of the issue, with the Association of Organ Procurement Organizations noting that over 104,000 patients are on the national waiting list for transplants in 2025. This figure emphasizes the disconnect between available resources and clinical necessity, as the number of candidates vastly outnumbers the donor pool. Consequently, revenue potential for manufacturers of preservation devices is capped, preventing the market from fully capitalizing on the demand suggested by the global prevalence of chronic diseases.

Market Trends

The market is being reshaped by the rise of outsourcing models and organ care services, moving the focus from capital equipment purchases to comprehensive logistical support. Transplant centers and hospitals are increasingly utilizing turnkey service networks that handle the entire process of organ retrieval, perfusion, and transport, significantly easing the operational load on surgical teams. This shift allows medical institutions to leverage advanced perfusion technologies without heavy upfront investments in hardware or specialized staff; illustrating this trend, Medical Buyer reported in October 2025 that TransMedics Group achieved a 32 percent quarterly revenue increase to USD 143.8 million, driven largely by the growing use of its National OCS Program (NOP) logistics network rather than console sales alone.

In parallel, the advancement of automated and portable organ transport systems is revolutionizing donor organ mobility and improving post-transplant outcomes. Unlike traditional static cold storage, these sophisticated devices actively regulate and monitor the organ's environment during transport, providing protection that substantially lowers long-term clinical risks. Integrating temperature control and continuous monitoring into a portable unit is yielding tangible survival benefits; the Organ Donation Alliance reported in June 2025 that data from the GUARDIAN-Heart Registry showed a 54 percent reduction in four-year mortality rates for hearts preserved with the Paragonix SherpaPak System compared to those transported using standard ice storage.

Key Market Players

• Paragonix Technologies, Inc
• XVIVO Perfusion AB
• Dr. Franz KOhler Chemie GmbH
• OrganOx Limited
• Bridge to Life (Europe) Ltd.
• Waters Medical Systems, LLC
• Preservation Solutions Inc.
• Artivion, Inc
• Vascular Perfusion Solutions, Inc
• Global Transplant Solutions

Report Scope

In this report, the Global Organ Preservation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Preservation Market, By Solution

• University of Wisconsin Solution (UW Solution)
• Custodial HTK
• Perfadex
• Other Solutions

Organ Preservation Market, By Technique

• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion

Organ Preservation Market, By Organ Type

• Kidney
• Liver
• Lung
• Heart
• Pancreas

Organ Preservation Market, By End User

• Organ Transplant Centers
• Hospitals
• Specialty Clinics

Organ Preservation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ Preservation Market.

Available Customizations:

Global Organ Preservation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ Preservation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Solution (University of Wisconsin Solution (UW Solution), Custodial HTK, Perfadex, Other Solutions)
  • 5.2.2. By Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion)
  • 5.2.3. By Organ Type (Kidney, Liver, Lung, Heart, Pancreas)
  • 5.2.4. By End User (Organ Transplant Centers, Hospitals, Specialty Clinics)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Organ Preservation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Solution
  • 6.2.2. By Technique
  • 6.2.3. By Organ Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organ Preservation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Solution
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Organ Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Organ Preservation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Solution
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Organ Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Organ Preservation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Solution
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Organ Type
      • 6.3.3.2.4. By End User

7. Europe Organ Preservation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Solution
  • 7.2.2. By Technique
  • 7.2.3. By Organ Type
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organ Preservation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Solution
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Organ Type
      • 7.3.1.2.4. By End User
  • 7.3.2. France Organ Preservation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Solution
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Organ Type
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Organ Preservation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Solution
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Organ Type
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Organ Preservation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Solution
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Organ Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Organ Preservation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Solution
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Organ Type
      • 7.3.5.2.4. By End User

8. Asia Pacific Organ Preservation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Solution
  • 8.2.2. By Technique
  • 8.2.3. By Organ Type
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Organ Preservation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Solution
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Organ Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Organ Preservation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Solution
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Organ Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Organ Preservation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Solution
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Organ Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Organ Preservation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Solution
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Organ Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Organ Preservation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Solution
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Organ Type
      • 8.3.5.2.4. By End User

9. Middle East & Africa Organ Preservation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Solution
  • 9.2.2. By Technique
  • 9.2.3. By Organ Type
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Organ Preservation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Solution
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Organ Type
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Organ Preservation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Solution
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Organ Type
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Organ Preservation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Solution
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Organ Type
      • 9.3.3.2.4. By End User

10. South America Organ Preservation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Solution
  • 10.2.2. By Technique
  • 10.2.3. By Organ Type
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Organ Preservation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Solution
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Organ Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Organ Preservation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Solution
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Organ Type
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Organ Preservation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Solution
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Organ Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Organ Preservation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Paragonix Technologies, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. XVIVO Perfusion AB
• 15.3. Dr. Franz KOhler Chemie GmbH
• 15.4. OrganOx Limited
• 15.5. Bridge to Life (Europe) Ltd.
• 15.6. Waters Medical Systems, LLC
• 15.7. Preservation Solutions Inc.
• 15.8. Artivion, Inc
• 15.9. Vascular Perfusion Solutions, Inc
• 15.10. Global Transplant Solutions

16. Strategic Recommendations

17. About Us & Disclaimer